Stock Analysis Report

Header cover image

Executive Summary

AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets.

Snowflake Analysis

Solid track record with adequate balance sheet and pays a dividend.

Similar Companies

Share Price & News

How has AptarGroup's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: ATR has not had significant price volatility in the past 3 months.

Market Performance

7 Day Return




US Packaging


US Market

1 Year Return




US Packaging


US Market

Return vs Industry: ATR matched the US Packaging industry which returned -6.9% over the past year.

Return vs Market: ATR underperformed the US Market which returned 6.7% over the past year.

Shareholder returns

7 Day-1.6%-2.3%-0.7%
30 Day7.7%1.8%4.6%
90 Day9.0%4.5%14.0%
1 Year-6.6%-7.7%-3.8%-6.0%7.6%5.3%
3 Year31.5%26.3%-1.4%-8.2%34.9%26.1%
5 Year90.8%77.3%31.0%14.1%62.3%44.7%

Price Volatility Vs. Market

How volatile is AptarGroup's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is AptarGroup undervalued compared to its fair value and its price relative to the market?


Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: ATR ($113.43) is trading above our estimate of fair value ($110.55)

Significantly Below Fair Value: ATR is trading above our estimate of fair value.

Price To Earnings Ratio

PE vs Industry: ATR is poor value based on its PE Ratio (30.9x) compared to the US Packaging industry average (16.6x).

PE vs Market: ATR is poor value based on its PE Ratio (30.9x) compared to the US market (16.2x).

Price to Earnings Growth Ratio

PEG Ratio: ATR is poor value based on its PEG Ratio (2.5x)

Price to Book Ratio

PB vs Industry: ATR is overvalued based on its PB Ratio (4.6x) compared to the US Packaging industry average (2.9x).

Next Steps

Future Growth

How is AptarGroup forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ATR's forecast earnings growth (12.3% per year) is above the savings rate (2.2%).

Earnings vs Market: ATR's earnings (12.3% per year) are forecast to grow slower than the US market (22.9% per year).

High Growth Earnings: ATR's earnings are forecast to grow, but not significantly.

Revenue vs Market: ATR's revenue (5.1% per year) is forecast to grow slower than the US market (9.4% per year).

High Growth Revenue: ATR's revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ATR's Return on Equity is forecast to be low in 3 years time (15.4%).

Next Steps

Past Performance

How has AptarGroup performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ATR has high quality earnings.

Growing Profit Margin: ATR's current net profit margins (8.3%) are higher than last year (7.1%).

Past Earnings Growth Analysis

Earnings Trend: ATR's earnings have grown by 3.4% per year over the past 5 years.

Accelerating Growth: ATR's earnings growth over the past year (18%) exceeds its 5-year average (3.4% per year).

Earnings vs Industry: ATR earnings growth over the past year (18%) exceeded the Packaging industry 1.4%.

Return on Equity

High ROE: ATR's Return on Equity (14.8%) is considered low.

Next Steps

Financial Health

How is AptarGroup's financial position?

Financial Position Analysis

Short Term Liabilities: ATR's short term assets ($1.5B) exceed its short term liabilities ($891.3M).

Long Term Liabilities: ATR's short term assets ($1.5B) exceed its long term liabilities ($1.3B).

Debt to Equity History and Analysis

Debt Level: ATR's debt to equity ratio (84%) is considered high.

Reducing Debt: ATR's debt to equity ratio has increased from 81.1% to 84% over the past 5 years.

Debt Coverage: ATR's debt is well covered by operating cash flow (39.2%).

Interest Coverage: ATR's interest payments on its debt are well covered by EBIT (12x coverage).

Balance Sheet

Next Steps


What is AptarGroup current dividend yield, its reliability and sustainability?


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: ATR's dividend (1.27%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.68%).

High Dividend: ATR's dividend (1.27%) is low compared to the top 25% of dividend payers in the US market (4.6%).

Stability and Growth of Payments

Stable Dividend: ATR's dividends per share have been stable in the past 10 years.

Growing Dividend: ATR's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (39.2%), ATR's dividend payments are well covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: ATR's dividends in 3 years are forecast to be well covered by earnings (37.4% payout ratio).

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Stephan Tanda (55yo)





Mr. Stephan B. Tanda, MBA, serves as an Independent Director at Ingredion Incorporated since August 19, 2019. He has been Chief Executive Officer and President at AptarGroup, Inc. since February 01, 2017.  ...

CEO Compensation Analysis

Compensation vs Market: Stephan's total compensation ($USD7.92M) is about average for companies of similar size in the US market ($USD7.34M).

Compensation vs Earnings: Stephan's compensation has been consistent with company performance over the past year.

Leadership Team

Stephan Tanda
President3.42yrsUS$7.92m0.067% $4.9m
Robert Kuhn
Executive VP11.83yrsUS$3.67m0.11% $8.1m
Eldon Schaffer
Executive Vice President of Strategic Projects & Commercial Excellence0.58yrUS$2.19m0.072% $5.3m
Gael Touya
President of Aptar Pharma4.5yrsUS$3.31m0.049% $3.6m
Xiangwei Gong
President of Aptar Asia1.75yrsUS$1.57m0.035% $2.6m
Matthew DellaMaria
Senior VP of Investor Relations & Communicationsno datano datano data
Shiela Vinczeller
Chief Human Resources Officer1.67yrsno data0.017% $1.2m
Marc Prieur
President of Aptar Beauty + Home1.83yrsno data0.018% $1.3m
Heidi Tlili
President of Aptar Food + Beverage0.58yrno data0.015% $1.1m


Average Tenure


Average Age

Experienced Management: ATR's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

Stephan Tanda
President3.42yrsUS$7.92m0.067% $4.9m
George Fotiades
Independent Chairman2.17yrsUS$350.00k0.023% $1.7m
Joanne Smith
Independent Director21.5yrsUS$257.00k0.024% $1.8m
B. Owens
Independent Director2.42yrsUS$255.00k0.0063% $456.5k
Ralf Wunderlich
Independent Director11.17yrsUS$247.00k0.018% $1.3m
Giovanna Kampouri Monnas
Independent Director10.17yrsUS$262.00k0.016% $1.2m
Isabelle Marey-Semper
Independent Director1.17yrsUS$247.00k0.0041% $296.3k
Andreas Kramvis
Independent Director6.33yrsUS$253.00k0.015% $1.1m
Jen-Wei Wu
Independent Director2.42yrsUS$247.00k0.0063% $456.5k
Maritza Montiel
Independent Director5.5yrsUS$268.00k0.0067% $491.4k


Average Tenure


Average Age

Experienced Board: ATR's board of directors are considered experienced (4.5 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: ATR insiders have only sold shares in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

AptarGroup, Inc.'s company bio, employee growth, exchange listings and data sources

Key Information

  • Name: AptarGroup, Inc.
  • Ticker: ATR
  • Exchange: NYSE
  • Founded: 1992
  • Industry: Metal and Glass Containers
  • Sector: Materials
  • Market Cap: US$7.281b
  • Shares outstanding: 64.19m
  • Website: https://www.aptar.com

Number of Employees


  • AptarGroup, Inc.
  • 265 Exchange Drive
  • Suite 100
  • Crystal Lake
  • Illinois
  • 60014
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ATRNYSE (New York Stock Exchange)YesCommon StockUSUSDApr 1993
AGTDB (Deutsche Boerse AG)YesCommon StockDEEURApr 1993


AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components components to the beauty market. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; and elastomer for injectable primary packaging components. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company also manufactures and sells elastomeric primary packaging components for injectable market, which include stoppers for infusion, antibiotic, lyophilization, and diagnostic vials; and pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, and dropper bulbs and syringe plungers. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was founded in 1992 and is headquartered in Crystal Lake, Illinois. 

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/07/13 23:53
End of Day Share Price2020/07/13 00:00
Annual Earnings2019/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.